Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 4.

Cahn, Pedro; Madero, Juan Sierra; Arribas, José Ramón; Antinori, Andrea; Ortiz, Roberto; Clarke, Amanda E; Hung, Chien-Ching; Rockstroh, Jürgen K; Girard, Pierre-Marie; Sievers, Jörg; Man, Choy; Currie, Alexander; Underwood, Mark; Tenorio, Allan R; Pappa, Keith; Wynne, Brian; Fettiplace, Anna; Gartland, Martin; Aboud, Michael; Smith, Kimberly; GEMINI Study Team (2019). Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials. The Lancet, 393(10167):143-155.

Wang, Qing; De Luca, Andrea; Smith, Colette; Zangerle, Robert; Sambatakou, Helen; Bonnet, Fabrice; Smit, Colette; Schommers, Philipp; Thornton, Alicia; Berenguer, Juan; Peters, Lars; Spagnuolo, Vincenzo; Ammassari, Adriana; Antinori, Andrea; Roldan, Eugenia Quiros; Mussini, Cristina; Miro, Jose M; Konopnicki, Deborah; Fehr, Jan; Campbell, Maria A; Termote, Monique; Bucher, Heiner C; Hepatitis Coinfection and Non Hodgkin Lymphoma project team for (2017). Chronic hepatitis B and C virus infection and risk for non-hodgkin lymphoma in HIV-infected patients: a cohort study. Annals of Internal Medicine, 166(1):9-17.

Antinori, Andrea; Clarke, Amanda; Svedhem-Johansson, Veronika; Arribas, José R; Arenas-Pinto, Alejandro; Fehr, Jan; Gerstoft, Jan; Horban, Andrzej; Clotet, Bonaventura; Ripamonti, Diego; Girard, Pierre-Marie; Hill, Andrew M; Moecklinghoff, Christiane (2015). Week 48 efficacy and central nervous system analysis of darunavir/ritonavir monotherapy versus darunavir/ritonavir with two nucleoside analogues. AIDS, 29(14):1811-1820.

Clotet, Bonaventura; Feinberg, Judith; van Lunzen, Jan; Khuong-Josses, Marie-Aude; Antinori, Andrea; Dumitru, Irina; Pokrovskiy, Vadim; Fehr, Jan; Ortiz, Roberto; Saag, Michael; Harris, Julia; Brennan, Clare; Fujiwara, Tamio; Min, Sherene (2014). Once-daily dolutegravir versus darunavir plus ritonavir in antiretroviral-naive adults with HIV-1 infection (FLAMINGO): 48 week results from the randomised open-label phase 3b study. Lancet, 383(9936):2222-31.

This list was generated on Wed Jul 24 01:21:13 2019 CEST.